Document Detail

HIV-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest Uganda, 2004-2010.
MedLine Citation:
PMID:  23046049     Owner:  NLM     Status:  MEDLINE    
The high diversity of HIV-1 has been shown to affect disease progression, transmission, and response to antiretroviral therapy and may influence HIV vaccine design. We describe the distribution trends of HIV-1 subtypes over a 7-year period among incident cases in a rural clinical cohort in Southwest Uganda and identify transmission clusters. Viral RNA was extracted from cryopreserved plasma samples from 94 participants who seroconverted and enrolled between 2004 and 2010. Partial gag (p24) and env (gp41) genes were directly sequenced to identify subtypes and transmission clusters with more than 95% bootstrap values. Direct sequencing of the partial pol gene and use of individual participant sexual life histories were also used to confirm these transmission clusters. The overall gag/env subtype distribution was A 28% (n=26), C 1% (n=1), and D 45% (n=42) and 27% (n=25) were intergene unique recombinant forms. The proportions of subtype A, D, or recombinants showed no significant increasing or decreasing trend over this time period (p=0.51). Phylogenetic analysis of the three genes confirmed 13 transmission clusters of which seven clusters were confirmed sexual partners using individual participants' sexual life histories. Subtype D has remained the predominant subtype in this population. From 2004 to 2010, there was no change in the proportions of these subtypes. Phylogenetic analysis and participants' sexual life histories revealed several transmission clusters. The high proportion of transmission clusters observed suggests continued high-risk sexual behavior and mixing in some individuals and possibly super transmitters in this presumed low-risk cohort, but also indicates that many transmissions occur in early HIV infection. This calls for early and targeted effective prevention and treatment intervention in this population.
Anne Kapaata; Frederick Lyagoba; Deogratius Ssemwanga; Brian Magambo; Maria Nanyonjo; Jonathan Levin; Billy N Mayanja; Claire Mugasa; Chris M Parry; Pontiano Kaleebu
Related Documents :
24580859 - Sero-prevalence and risk factors of hepatitis b virus and human immunodeficiency virus ...
24356869 - Early male partnership patterns, social support, and sexual risk behavior among young m...
23906419 - Hiv seroprevalence among inmates in togo.
23343909 - Incident tuberculosis and risk factors among hiv-infected children in dar es salaam, ta...
23850879 - Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatit...
24033899 - Bcn checkpoint, a community-based centre for men who have sex with men in barcelona, ca...
16971279 - Vulnerability and risk factors for sexually transmitted infections and hiv among adoles...
7595609 - Sporadic als/mnd: a global neurodegeneration with retroviral involvement?
10660969 - Comparison between reverse transcription-polymerase chain reaction and immune enzyme as...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-12-16
Journal Detail:
Title:  AIDS research and human retroviruses     Volume:  29     ISSN:  1931-8405     ISO Abbreviation:  AIDS Res. Hum. Retroviruses     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-26     Completed Date:  2013-08-02     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  8709376     Medline TA:  AIDS Res Hum Retroviruses     Country:  United States    
Other Details:
Languages:  eng     Pagination:  520-7     Citation Subset:  IM; X    
Data Bank Information
Bank Name/Acc. No.:
GENBANK/JQ291382;  JQ291383;  JQ291384;  JQ291385;  JQ291386;  JQ291387;  JQ291388;  JQ291389;  JQ291390;  JQ291391;  JQ291392;  JQ291393;  JQ291394;  JQ291395;  JQ291396;  JQ291397;  JQ291398;  JQ291399;  JQ291400;  JQ291401;  JQ291402;  JQ291403;  JQ291404;  JQ291405;  JQ291406;  JQ291407;  JQ291408;  JQ291409;  JQ291410;  JQ291411;  JQ291412;  JQ291413;  JQ291414;  JQ291415;  JQ291416;  JQ291417;  JQ291418;  JQ291419;  JQ291420;  JQ291421;  JQ291422;  JQ291423;  JQ291424;  JQ291425;  JQ291426;  JQ291427;  JQ291428;  JQ291429;  JQ291430;  JQ291431;  JQ291432;  JQ291433;  JQ291434;  JQ291435;  JQ291436;  JQ291437;  JQ291438;  JQ291439;  JQ291440;  JQ291441;  JQ291442;  JQ291443;  JQ291444;  JQ291445;  JQ291446;  JQ291447;  JQ291448;  JQ291449;  JQ291450;  JQ291451;  JQ291452;  JQ291453;  JQ291454;  JQ291455;  JQ291456;  JQ291457;  JQ291458;  JQ291459;  JQ291460;  JQ291461;  JQ291462;  JQ291463;  JQ291464;  JQ291465;  JQ291466;  JQ291467;  JQ291468;  JQ291469;  JQ291470;  JQ291471;  JQ291472;  JQ291473;  JQ291474;  JQ291475;  JQ291476;  JQ291477;  JQ291478;  JQ291479;  JQ291480;  JQ291481;  JQ291482;  JQ291483;  JQ291484;  JQ291485;  JQ291486;  JQ291487;  JQ291488;  JQ291489;  JQ291490;  JQ291491;  JQ291492;  JQ291493;  JQ291494;  JQ291495;  JQ291496;  JQ291497;  JQ291498;  JQ291499;  JQ291500;  JQ291501;  JQ291502;  JQ291503;  JQ291504;  JQ291505;  JQ291506;  JQ291507;  JQ291508;  JQ291509;  JQ291510;  JQ291511;  JQ291512;  JQ291513;  JQ291514;  JQ291515;  JQ291516;  JQ291517;  JQ291518;  JQ291519;  JQ291520;  JQ291521;  JQ291522;  JQ291523;  JQ291524;  JQ291525;  JQ291526;  JQ291527;  JQ291528;  JQ291529;  JQ291530;  JQ291531;  JQ291532;  JQ291533;  JQ291534;  JQ291535;  JQ291536;  JQ291537;  JQ291538;  JQ291539;  JQ291540;  JQ291541;  JQ291542;  JQ291543;  JQ291544;  JQ291545;  JQ291546;  JQ291547;  JQ291548;  JQ291549;  JQ291550;  JQ291551;  JQ291552;  JQ291553;  JQ291554;  JQ291555;  JQ291556;  JQ291557;  JQ291558;  JQ291559;  JQ291560;  JQ291561;  JQ291562;  JQ291563
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cluster Analysis
Genetic Variation*
HIV Infections / transmission*,  virology*
HIV-1 / classification*,  genetics*,  isolation & purification
Molecular Epidemiology
Molecular Sequence Data
RNA, Viral / genetics
Rural Population
Sequence Analysis, DNA
Uganda / epidemiology
env Gene Products, Human Immunodeficiency Virus / genetics
gag Gene Products, Human Immunodeficiency Virus / genetics
pol Gene Products, Human Immunodeficiency Virus / genetics
Grant Support
MC_U950080928//Medical Research Council; MC_U950097144//Medical Research Council; //Medical Research Council
Reg. No./Substance:
0/RNA, Viral; 0/env Gene Products, Human Immunodeficiency Virus; 0/gag Gene Products, Human Immunodeficiency Virus; 0/pol Gene Products, Human Immunodeficiency Virus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential roles of Arabidopsis Dynamin-Related Proteins DRP3A, DRP3B, and DRP5B in Organelle Divi...
Next Document:  Synthetic control of composition and crystallite size of silver hollandite, Ag(x)Mn8O16: impact on e...